A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT)

BACKGROUND: Isavuconazole is a broad-spectrum triazole approved for treatment of invasive fungal infections (IFI). We evaluated isavuconazole for antifungal prophylaxis after allogeneic hematopoietic cell transplant (HCT). MATERIALS AND METHODS: In this open-label, single-arm study, adult patients a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Stern, Anat, Su, Yiqi, Lee, Yeon Joo, Seo, Susan, Shaffer, Brian, Tamari, Roni, Gyurkocza, Boglarka, Barker, Juliet, Bogler, Yael, Giralt, Sergio, Perales, Miguel, Papanicolaou, Genovefa A
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8210627/
https://ncbi.nlm.nih.gov/pubmed/32088367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.02.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados